Company / Return on Equity (ROE)
UTAH MEDICAL PRODUCTS INC Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
14.0%
FY2025
5-year range
2.9% / 14.0%
FY2021-FY2025
Trend
-0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) has fluctuated over the past 10 years, ranging from 2.9% in FY2022 to 18.1% in FY2020.
Based on SEC 10-K filings.
14.0% in FY2025 with a 5-year CAGR of -4.1%.
Improved from 12.9% to 14.0% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +11.0pp
- 5-Year Change
- -4.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 0.6% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.0% | -0.6% |
| FY2024 | 14.0% | +8.4% |
| FY2023 | 12.9% | +341.6% |
| FY2022 | 2.9% | -78.7% |
| FY2021 | 13.8% | -23.8% |
| FY2020 | 18.1% | +114.6% |
| FY2019 | 8.4% | -38.3% |
| FY2018 | 13.6% | -10.1% |
| FY2017 | 15.2% | -14.0% |
| FY2016 | 17.6% | -6.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026